Agency Forms Undergoing Paperwork Reduction Act Review, 9622-9623 [2022-03709]
Download as PDF
9622
Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Cooperative Agreement To Fund the
Kazakhstan Scientific Center for
Dermatology and Infectious Diseases
(KSCDID)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $500,000, for
Year 1 of funding to the Kazakhstan
Scientific Center for Dermatology and
Infectious Diseases (KSCDID). The
award will reduce new HIV infections
and AIDS deaths in Kazakhstan through
rapidly expanding prevention, testing,
care, and effective treatment services to
people living with HIV (PLHIV).
Funding amounts for years 2–5 will be
set at continuation.
DATES: The period for this award will be
September 30, 2022 through September
29, 2027.
FOR FURTHER INFORMATION CONTACT:
Patrick Nadol, Center for Global Health,
Centers for Disease Control and
Prevention, 171 Prospect Mira, Bishkek,
720016, Kyrgyz Republic, Telephone:
800–232–6348, E-Mail: pen5@cdc.gov.
SUPPLEMENTARY INFORMATION: The
single-source award will implement
prevention, testing, care and treatment,
laboratory, and strategic information
activities in Kazakhstan. KSCDID is in a
unique position to conduct this work, as
it is the leading organization
implementing the National HIV program
in Kazakhstan; it will lead and sustain
the national HIV services for prevention,
testing, care, treatment, and strategic
information according to international
standards to achieve epidemic control
and ensure resilient and sustained
health care systems. KSCDID develops
policy and regulations, conducts
prevention and testing activities,
coordinates care and treatment, and is
responsible for quality assurance of
laboratory services.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
Summary of the Award
Recipient: Kazakhstan Scientific
Center for Dermatology and Infectious
Diseases (KSCDID).
Purpose of the Award: The purpose of
this award is to reduce new HIV
infections and AIDS deaths in
VerDate Sep<11>2014
19:42 Feb 18, 2022
Jkt 256001
Kazakhstan through rapidly expanding
prevention, testing, care, and effective
treatment services to PLHIV.
Amount of Award: The approximate
year 1 funding amount will be $500,000
in Federal Fiscal Year (FFY) 2022 funds,
subject to the availability of funds.
Funding amounts for years 2–5 will be
set at continuation.
Authority: This program is authorized
under Public Law 108–25 (the United
States Leadership Against HIV AIDS,
Tuberculosis and Malaria Act of 2003).
Period of Performance: September 30,
2022 through September 29, 2027.
Dated: February 15, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–03629 Filed 2–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–1268]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Drug Overdose
Surveillance and Epidemiology (DOSE)’’
to the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on April 26, 2021, to obtain
comments from the public and affected
agencies. CDC received four comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Drug Overdose Surveillance and
Epidemiology (DOSE) (OMB Control No.
0920–1268, Exp. 8/31/2022)—
Revision—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In 2020, a total of 91,799 drug
overdose deaths occurred,
corresponding to an age-adjusted rate of
28.3 per 100,000 population and a 31%
increase from the 2019 rate (21.6). From
2013 to 2019, the synthetic opioidinvolved death rate increased 1,040%,
from 1.0 to 11.4 per 100,000 ageadjusted (3,105 to 36,359). The
psychostimulant-involved death rate
increased 317%, from 1.2 (3,627) in
2013 to 5.0 (16,167) in 2019. Non-fatal
overdoses are on the rise as well;
Emergency Department (ED) data from
DOSE indicates increases from 2018 to
present. In response to the growing
severity of the opioid overdose
epidemic, the U.S. government declared
the opioid overdose epidemic a public
health emergency on October 26, 2017.
The opioid overdose epidemic is one of
the top priorities of the U.S. Department
of Health and Human Services (HHS). In
E:\FR\FM\22FEN1.SGM
22FEN1
9623
Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices
2021, HHS expanded their Overdose
Prevention Strategy to focus on four
strategic priorities: Primary prevention,
harm reduction, evidence-based
treatment, and recovery support.
DOSE is a critical element of HHS’s
first goal under primary prevention to
support research and surveillance to
collect timelier and more specific data
through accelerating the speed at which
CDC reports drug overdose data. DOSE
data collection integrates, expands, and
enhances previous data sharing efforts
with public health departments initiated
under ESOOS. The goal of DOSE is to
conduct surveillance of approximately
75% of all ED visits for drug overdoses
through the end of the Overdose Data to
Action (OD2A) cooperative agreement
in 2023. In 2019, OD2A provided
funding for 66 jurisdictions; 47 states
and the District of Columbia share data
with DOSE. Though we had hoped to
capture data from all 50 states and the
District of Columbia, only 47 states and
the District of Columbia applied for this
funding announcement.
Currently, DOSE operates in the 47
states and the District of Columbia
currently funded by OD2A (three states
did not request CDC funding in the
current cycle but may for the next
funding cycle in 2023). Of these 48
health departments, 43 share syndromic
data with CDC monthly and 26 share at
least quarterly discharge data. A total of
33 health departments provide CDC
with access to their syndromic
surveillance data from EDs in CDC’s
National Syndromic Surveillance
Program (NSSP) system. Access to this
timely data has allowed us to improve
the situational awareness of federal,
state, and local health departments
about emerging drug overdose outbreaks
and the progression of the opioid
overdose epidemic. Health departments
have used this data to populate state
data dashboards and develop alerts for
local communities. In addition, health
departments have used this data in
concert with public safety partners to
gain a better overall picture of outbreaks
in their communities.
All data sharing between CDC and
health departments in DOSE is driven
by two standardized data forms, the
Rapid ED overdose data form and the
ED discharge overdose data form, and
CDC cases definitions of drug, opioid,
heroin, fentanyl, all stimulant, cocaine,
methamphetamine, benzodiazepine, and
other emerging drug overdoses. The
Rapid ED Overdose Data Form will be
submitted to CDC monthly. For 35
respondents, the estimated burden per
response is 30 minutes. For 10
respondents, the estimated burden per
response is three hours. The estimated
burden per response for the ED
Discharge Overdose Data Form is three
hours. This form will be submitted four
times per year by 28 respondents and
once per year by 23 respondents. All
information will be collected
electronically. The total estimated
annualized burden hours are 975.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(hours)
Form name
Participating health departments sharing aggregate data
from local syndromic or hospital discharge file.
Participating health departments sharing case-level ED data
with CDC through the NSSP BioSense (OMB No. 0920–
0824).
Participating health department sharing finalized hospital discharge data on a quarterly basis.
Participating health department sharing finalized hospital discharge data on a yearly basis.
Rapid ED overdose data form
10
12
3
Rapid ED overdose data form
35
12
30/60
ED discharge overdose data
form.
ED discharge overdose data
form.
28
4
3
23
1
3
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–03709 Filed 2–18–22; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Cooperative Agreement To Fund the
Ho Chi Minh City Department of Health
(HCMC DOH), Vietnam
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondent
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
SUMMARY:
VerDate Sep<11>2014
19:42 Feb 18, 2022
Jkt 256001
within the Department of Health and
Human Services (HHS), announces the
award of approximately $2,000,000 for
Year 1 of funding to the Ho Chi Minh
City Department of Health (HCMC
DOH). The award will strengthen the
capacity of the HCMC DOH to provide
sustainable evidence-based effective
HIV prevention, care and treatment
services. As Ho Chi Minh City
contributes to 22.6% of the HIV burden,
HCMC DOH remains critical to the
success of HIV program in Vietnam.
This NOFO will contribute directly to
the national HIV prevention, care and
treatment goals by supporting direct
services and will support long-term
sustainability of the HIV response
through capacity building and technical
assistance (TA). Funding amounts for
years 2–5 will be set at continuation.
The period for this award will be
September 30, 2022 through September
29, 2027.
DATES:
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Amy Bailey, Center for Global Health,
Centers for Disease Control and
Prevention, 4 Le Duan, District 1, Ho
Chi Minh City, Vietnam, Telephone:
800–232–6348, E-Mail: fue8@cdc.gov.
SUPPLEMENTARY INFORMATION: The
single-source award will strengthen the
capacity of the HCMC DOH to provide
sustainable, evidence-based, effective
HIV/AIDS prevention, care and
treatment services.
HCMC DOH is in a unique position to
conduct this work as it is mandated to
advise and assist the City People’s
Committee in state management of
health and in terms of legal authority
and credibility among Vietnamese
health institutions, to give direction,
guide, coordinate and implement all
public health including HIV/AIDS
activities in HCMC. As Ho Chi Minh
City (HCMC) contributes to 22.6% of the
HIV burden, HCMC DOH remains
critical to the success of HIV program in
E:\FR\FM\22FEN1.SGM
22FEN1
Agencies
[Federal Register Volume 87, Number 35 (Tuesday, February 22, 2022)]
[Notices]
[Pages 9622-9623]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03709]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-1268]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Drug Overdose Surveillance and Epidemiology
(DOSE)'' to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on April 26,
2021, to obtain comments from the public and affected agencies. CDC
received four comments related to the previous notice. This notice
serves to allow an additional 30 days for public and affected agency
comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Drug Overdose Surveillance and Epidemiology (DOSE) (OMB Control No.
0920-1268, Exp. 8/31/2022)--Revision--National Center for Injury
Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In 2020, a total of 91,799 drug overdose deaths occurred,
corresponding to an age-adjusted rate of 28.3 per 100,000 population
and a 31% increase from the 2019 rate (21.6). From 2013 to 2019, the
synthetic opioid-involved death rate increased 1,040%, from 1.0 to 11.4
per 100,000 age-adjusted (3,105 to 36,359). The psychostimulant-
involved death rate increased 317%, from 1.2 (3,627) in 2013 to 5.0
(16,167) in 2019. Non-fatal overdoses are on the rise as well;
Emergency Department (ED) data from DOSE indicates increases from 2018
to present. In response to the growing severity of the opioid overdose
epidemic, the U.S. government declared the opioid overdose epidemic a
public health emergency on October 26, 2017. The opioid overdose
epidemic is one of the top priorities of the U.S. Department of Health
and Human Services (HHS). In
[[Page 9623]]
2021, HHS expanded their Overdose Prevention Strategy to focus on four
strategic priorities: Primary prevention, harm reduction, evidence-
based treatment, and recovery support.
DOSE is a critical element of HHS's first goal under primary
prevention to support research and surveillance to collect timelier and
more specific data through accelerating the speed at which CDC reports
drug overdose data. DOSE data collection integrates, expands, and
enhances previous data sharing efforts with public health departments
initiated under ESOOS. The goal of DOSE is to conduct surveillance of
approximately 75% of all ED visits for drug overdoses through the end
of the Overdose Data to Action (OD2A) cooperative agreement in 2023. In
2019, OD2A provided funding for 66 jurisdictions; 47 states and the
District of Columbia share data with DOSE. Though we had hoped to
capture data from all 50 states and the District of Columbia, only 47
states and the District of Columbia applied for this funding
announcement.
Currently, DOSE operates in the 47 states and the District of
Columbia currently funded by OD2A (three states did not request CDC
funding in the current cycle but may for the next funding cycle in
2023). Of these 48 health departments, 43 share syndromic data with CDC
monthly and 26 share at least quarterly discharge data. A total of 33
health departments provide CDC with access to their syndromic
surveillance data from EDs in CDC's National Syndromic Surveillance
Program (NSSP) system. Access to this timely data has allowed us to
improve the situational awareness of federal, state, and local health
departments about emerging drug overdose outbreaks and the progression
of the opioid overdose epidemic. Health departments have used this data
to populate state data dashboards and develop alerts for local
communities. In addition, health departments have used this data in
concert with public safety partners to gain a better overall picture of
outbreaks in their communities.
All data sharing between CDC and health departments in DOSE is
driven by two standardized data forms, the Rapid ED overdose data form
and the ED discharge overdose data form, and CDC cases definitions of
drug, opioid, heroin, fentanyl, all stimulant, cocaine,
methamphetamine, benzodiazepine, and other emerging drug overdoses. The
Rapid ED Overdose Data Form will be submitted to CDC monthly. For 35
respondents, the estimated burden per response is 30 minutes. For 10
respondents, the estimated burden per response is three hours. The
estimated burden per response for the ED Discharge Overdose Data Form
is three hours. This form will be submitted four times per year by 28
respondents and once per year by 23 respondents. All information will
be collected electronically. The total estimated annualized burden
hours are 975.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (hours)
----------------------------------------------------------------------------------------------------------------
Participating health departments Rapid ED overdose data 10 12 3
sharing aggregate data from local form.
syndromic or hospital discharge file.
Participating health departments Rapid ED overdose data 35 12 30/60
sharing case-level ED data with CDC form.
through the NSSP BioSense (OMB No.
0920-0824).
Participating health department ED discharge overdose 28 4 3
sharing finalized hospital discharge data form.
data on a quarterly basis.
Participating health department ED discharge overdose 23 1 3
sharing finalized hospital discharge data form.
data on a yearly basis.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-03709 Filed 2-18-22; 8:45 am]
BILLING CODE 4163-19-P